Latest 10-K annual reports
NASDAQ
Corner Growth Acquisition Corp. 2, a blank check company, has extended its business combination deadline to December 31, 2025, following its delisting from Nasdaq and significant shareholder redemptions, while reporting a net income driven by debt forgiveness.
OQB
Avant Technologies Inc. reported a net loss of $1.14 million for fiscal year 2025, continuing its history of unprofitability and raising substantial doubt about its ability to continue as a going concern, despite strategic AI acquisitions and a planned pursuit of new financing.
OTC.Pink
ORIB
Orion Bliss CORPOrion Bliss Corp.'s latest 10-K filing reveals a significant reduction in net loss and substantial revenue growth for fiscal year 2025, despite ongoing concerns about its ability to continue as a going concern and identified material weaknesses in internal controls.
OTC.Pink
UN MONDE INTERNATIONAL LTD.'s latest 10-K filing reveals a development-stage company with no revenue, recurring losses, and significant financial liabilities, raising substantial doubt about its ability to continue as a going concern.
OID
Resonate Blends, Inc. reported a substantial increase in net loss and working capital deficit for the fiscal year ended December 31, 2024, raising significant doubt about its ability to continue as a going concern, despite a surge in revenue driven by a recent acquisition.
Adapti, Inc.'s latest annual report reveals a precarious financial state with recurring losses and negative working capital, while the company attempts to pivot through unproven AI technology and uncertain strategic acquisitions.
OQX
Butler National Corporation announced a 7% increase in total revenue to $84.0 million for fiscal year 2025, primarily fueled by a 15% surge in its Aerospace Products segment, while operating income climbed 27% to $16.8 million.
OQB
Monroe Federal Bancorp, Inc. reported a net loss of $327,000 for the fiscal year ended March 31, 2025, a significant decline from the prior year's net income, driven by decreased assets, deposit outflows, and an increase in non-performing loans following its mutual-to-stock conversion.
OQB
Hong Yuan Holding Group, a development-stage company, reported its first significant revenue of $245,572 in 2024, primarily from consolidated Chinese VIEs, but continues to face substantial net losses, an accumulated deficit of $97.8 million, and a going concern qualification from its auditors.
NASDAQ
PODC
Podcastone, INC10-K: PodcastOne Reports 20% Revenue Growth Amidst Declining Downloads and Ongoing Going Concern Doubts
PodcastOne, Inc. announced a 20% increase in revenue for fiscal year 2025, reaching $52.1 million, despite a significant 44% decrease in podcast downloads and continued substantial net losses, raising substantial doubt about its ability to continue as a going concern.
OID
Antiaging Quantum Living Inc. (AAQL) reported a dramatic increase in revenue for the fiscal year ended March 31, 2025, driven by new technical support services, but continues to face substantial net losses and a going concern warning.
AMEX
Northann Corp.'s amended annual report for fiscal year 2024 reveals a substantial accumulated deficit, a net loss, and a going concern warning from auditors, despite an increase in revenue and gross profit.
NASDAQ
National Beverage Corp. reported a 0.8% increase in net sales to $1.2014 billion and a 5.7% rise in net income to $186.8 million for Fiscal 2025, driven by higher selling prices and reduced costs despite a slight decrease in case volume.
NASDAQ
Kewaunee Scientific Corporation reported increased sales driven by its Nu Aire acquisition but experienced a decline in net earnings for fiscal year 2025, while maintaining a strong order backlog.
NASDAQ
Aeries Technology Inc. reported a substantial net loss of $21.6 million for fiscal year 2025, alongside a working capital deficit and a significant customer contract non-renewal, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
Credo Technology Group Holding Ltd reported a significant financial turnaround in fiscal year 2025, achieving net income of $52.2 million on record revenue of $436.8 million, primarily fueled by surging demand for its high-speed connectivity solutions in AI and hyperscale data centers.
NASDAQ
Midland States Bancorp, Inc. has restated prior financial statements due to accounting errors in third-party loan programs, reported a substantial decline in 2024 net income, and anticipates a significant goodwill impairment charge in Q1 2025, reflecting deteriorating credit quality and strategic portfolio reductions.
OID
SUIC Worldwide Holdings Ltd. reported a net loss of $234,211 for fiscal year 2024, narrowing losses from the prior year, while continuing to develop its fintech and supply chain integration ventures.
AMEX
Northann Corp. reported a 10% increase in revenue and a significant improvement in gross profit for fiscal year 2024, driven by strategic acquisitions and a planned shift to U.S. manufacturing, despite a continued net loss and an auditor's going concern opinion.
OTC.Pink
10-K/A: IMAC Holdings Pivots to Oncology Proteomics Amidst Financial Restatement and Nasdaq Delisting
IMAC Holdings, Inc. has undergone a significant strategic shift, divesting its previous patient care operations to focus entirely on oncology proteomics, while simultaneously addressing a financial restatement and navigating a delisting from Nasdaq.
Qualigen Therapeutics, an early-clinical-stage oncology company, reported a significant net loss and accumulated deficit for 2024, raising substantial doubt about its ability to continue as a going concern, compounded by a Nasdaq delisting notice and a slowdown in its core therapeutic programs.
NASDAQ
CNVS
Cineverse CORPCineverse Corp. reported a substantial financial improvement for fiscal year 2025, moving from a net loss to net income and demonstrating strong revenue growth, primarily attributed to its expanding streaming business and key content releases.
OTC.Pink
10-K/A: Old Market Capital Amends Annual Report to Correct Audit Date and Internal Control Disclosure
Old Market Capital Corporation filed an amendment to its annual report to correct the audit report date and a disclosure regarding internal control over financial reporting.
AMEX
Perfect Moment Ltd. reported a substantial net loss of $15.9 million and a 12.1% revenue decrease in fiscal year 2025, prompting auditors to raise substantial doubt about its ability to continue as a going concern, despite ongoing strategic shifts and recent capital raises.
OTC.Pink
STEK
Stemtech CORPStemtech Corporation's latest 10-K filing reveals a reduced net loss and improved operating cash flow for 2024, yet highlights significant financial challenges including a substantial accumulated deficit, working capital deficiency, and material weaknesses in internal controls, raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
PTCO
Petrogas COPetroGas Company reported a net income of $8,978 for the fiscal year ended March 31, 2025, primarily due to a non-cash gain on asset retirement obligations, while continuing to face substantial doubt about its ability to continue as a going concern with no revenue generation and significant accumulated deficit.
NASDAQ
FATN
Fatpipe Inc/utFatPipe, Inc. reported a 9% decrease in fiscal year 2025 revenue to $16.29 million and a significant drop in net income, despite successfully completing its initial public offering and experiencing strong recurring billing growth.
OQB
10-K: Zoomcar Holdings Faces Going Concern Doubts Amidst Mounting Debt Defaults and Nasdaq Delisting
Zoomcar Holdings, Inc. reported a reduced net loss for the fiscal year ended March 31, 2025, driven by significant cost reductions, but faces substantial doubt about its ability to continue as a going concern due to critically deficient cash, ongoing debt defaults, and recent delisting from Nasdaq.
OQB
Sundance Strategies, Inc. filed its annual 10-K report for the fiscal year ended March 31, 2025, revealing ongoing net losses, increased cash burn from operations, and a continued heavy reliance on related-party debt and equity financing to sustain its new professional services business model in the life settlement industry.
OQB
10-K: Elite Pharmaceuticals Reports Strong Revenue Growth Amidst Net Loss and Intangible Asset Impairments
Elite Pharmaceuticals, Inc. announced a 48% increase in total revenue to $84.0 million for the fiscal year ended March 31, 2025, primarily due to four new product launches and increased sales from its Elite Label product line, though the company reported a net loss of $4.3 million and identified material weaknesses in internal controls.